key: cord-0930552-ery4w3rv authors: Broderick, Damian; Kyzas, Panayiotis; Baldwin, Andrew J.; Graham, Richard M.; Duncan, Tracy; Chaintoutis, Christos; Boultoukas, Evangelos; Vassiliou, Leandros title: Surgical tracheostomies in COVID-19 patients: A multidisciplinary approach and lessons learned date: 2020-05-03 journal: Oral Oncol DOI: 10.1016/j.oraloncology.2020.104767 sha: 84b605e456841339147b173531cb2ba7a400608e doc_id: 930552 cord_uid: ery4w3rv Surgical tracheostomies have a role in the weaning process of COVID-19 patients treated in intensive care units. A multidisciplinary team approach (MDT) is required for decision making. This process is augmented by specific standard operating practices implemented by senior clinicians. Here, we report on our early experience and outcomes with open tracheostomies in a cohort of COVID-19 patients. We outline the criteria that guide decision making and explore the challenges faced by our intensive care colleagues in the management of these patients. The cohort was 100% male with 90% of them having a raised Body Mass Index (BMI) and other comorbidities (hypertension and diabetes). 60% have been decannulated and have been stepped down the intensive care unit. We recorded no surgical complications or adverse events. The service to date has been shown to be effective, safe, largely reproducible and reflective. As the COVID-19 pandemic evolves, is evident that around 6% of the patients will require ICU admission [1] [2] [3] [4] . Around 75% of those will need invasive ventilation 4 , and approximately 10% will require ventilation beyond 14 days [5] [6] [7] [8] [9] . Undoubtedly, some patients will benefit from a tracheostomy during the weaning recovery phase. A tracheostomy is an aerosol generating procedure with a significant viral spread risk. Identifying who will benefit from it and developing safety procedure protocols requires clear selection criteria 10 . Details around operating protocols have been simultaneously published by our team 11 and an Italian group 12 . The "CORONA-steps" 12 and the "5Ts" 11 cover the entire spectrum of a safe tracheostomy procedure. Here we aim to share our outcomes in a cohort of COVID-19 patients that had surgical tracheostomies. We focus in selection criteria/outcomes, and share safety lessonslearned. Decisions were made on a case-by-case basis (communication between ICU-OMFS). Decision-making was based on acute and chronic co-morbidities such as acute kidney injury, obesity, anatomy, airway-related difficulties and ICU-related delirium/withdrawal. Prognosis (long-term, short-term) was also a decisive factor. Most ICU patients were heavily sedated and dependent on benzodiazepines and longacting opioid infusions; this increased the risk of sedation-related complications (withdrawal/delirium) during sedation holds and extubation attempts. We developed selection criteria and summarise them based on an 'ABCD' algorithm: All patients were male (average age 57.3) ( Table 1) . Lliterature supports male predominance, but reaching 100% was surprising 14 . Nine patients had co-morbidities. Nine had a BMI greater than 30, (>100Kg, <1.83m). Eight had pre-existing hypertension and 5 had pre-existing diabetes 15 . Five patients developed renal failure/undergoing haemodialysis. All patients were intubated for a minimum of 11 days. Due to body habitus we used a size-9 adjustable flange tube in 7/10 patients. We aimed to minimise the risk of inadvertent decannulation. We had no incidents of dislodgement. There were no significant intraoperative/immediate postoperative complications. Two patients experienced tracheostomy obstruction 72 hours post-procedure. Both were treated with change of inner cannula and bronchoscopy. One tube cuff deflated at day 8 post-op; this tube was changed uneventfully. Patients were able to wean-off sedation within 24hours. All patients required bridging with alternative sedatives (dexmedetomidine, clonidine). After each procedure, the team would debrief and reflect. An action plan was introduced to prevent recurring issues ( Table 2) . We aimed to identify human factors contributing towards safety pitfalls. The surgical team remained relatively constant but there was a considerable variation in the anaesthetic/scrub staff. This lack of continuity reinforced the need for a robust SOP and good communication. We also noticed that doing these cases on a CEPOD list takes longer. A potential solution to streamline the process might be for ICU units to consider a designated area in ICU for performing surgical tracheostomies. All personel used appropriate PPE 11 . None of the staff involved developed COVID-19 symptoms post-operatively (Appendix). One member of the team self-isolated for 2 weeks as his wife tested positive for COVID-19. He subsequently tested negative. This endorses the safety of our protocol. Our early experience with surgical tracheostomies in COVID-19 patients, suggests that this procedure has a positive effect on their outcome. 70% of our patients are no longer ventilator-dependant and 60% are decanulated. This releases valuable resources (ICU beds, staff,ventilators) to those that need them. Moreover, is a safe procedure both for patients and staff, if a well-considered SOP is followed. Our patients are chosen in a multidisciplinary setting, utilising the best available evidence. These patients tend to have a high BMI and various comorbidities. We recognise the expanding literature and we react accordingly adjusting our practice. It is important to remain adaptable in challenging times. Recognising the importance of human factors has significant benefits in providing safe/effective service. Our study has limitations. The sample size is low, but it reflects a significant % of our ICU capacity, translating into effctive resources' use. In addition, our cohort represents all of the patients undergone the procedure (no exclusions). Our study has no control group or experimental setting, as this wouldn't be appropriate, but data were kept in a prospective, protocol-driven fashion. Lastly, we haven't considered a comparison with percutaneous tracheostomies, as this is now considered a procedure with higher AGM transmission risk. Plus, none of our patients would qualify due to anatomy/obesity. Surgical tracheostomy is an invasive procedure with potentially significant risks. Decision-making should be based on MDT consensus and with a protocol to get the maximum benefit whilst minimizing risk. Doing this in a carefully planned and executed manner with strict inclusion criteria has a positive effect for the patients and the team. Clinical Characteristics of Coronavirus Disease 2019 in China Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China Surgical Considerations for Tracheostomy During the COVID-19 Pandemic: Lessons Learned From the Severe Acute Respiratory Syndrome Outbreak Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. The Lancet Respiratory Medicine Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Clinical features of patients infected with 2019 novel coronavirus in Wuhan Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. The Lancet Respiratory Medicine Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore ICNARC. ICNARC report on COVID-19 in critical care Chest CT for Typical 2019-nCoV Pneumonia: Relationship to Negative RT-PCTesting Sex difference and smoking predisposition in patients with COVID-19 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? The Lancet respiratory